Total Payments
$261,651
2024 Payments
$40,987
Companies
68
Transactions
904
Medicare Patients
6,073
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$195,369 (74.7%)
Consulting$36,613 (14.0%)
Food & Beverage$17,585 (6.7%)
Travel$12,044 (4.6%)
Education$39.95 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $195,369 | 103 | 74.7% |
| Consulting Fee | $36,613 | 15 | 14.0% |
| Food and Beverage | $17,585 | 726 | 6.7% |
| Travel and Lodging | $12,044 | 59 | 4.6% |
| Education | $39.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $161,443 | 200 | $0 (2022) |
| ABBVIE INC. | $81,044 | 146 | $0 (2024) |
| ARGENX US, INC. | $3,261 | 12 | $0 (2024) |
| Grifols USA, LLC | $2,737 | 14 | $0 (2020) |
| CATALYST PHARMACEUTICALS, INC. | $1,765 | 10 | $0 (2024) |
| Janssen Research & Development, LLC | $924.14 | 8 | $0 (2023) |
| UCB, Inc. | $764.15 | 40 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $671.03 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $586.02 | 31 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $543.04 | 40 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,987 | 125 | ABBVIE INC. ($37,454) |
| 2023 | $22,242 | 91 | ABBVIE INC. ($18,875) |
| 2022 | $26,089 | 87 | ABBVIE INC. ($16,907) |
| 2021 | $42,594 | 75 | Allergan, Inc. ($33,949) |
| 2020 | $33,362 | 102 | Allergan, Inc. ($30,972) |
| 2019 | $55,760 | 163 | Allergan Inc. ($54,162) |
| 2018 | $11,059 | 131 | Allergan Inc. ($8,149) |
| 2017 | $29,558 | 130 | Allergan Inc. ($26,165) |
All Payment Transactions
904 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: EPILEPSY | ||||||
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Genetic Disease | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: PAIN | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $91.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Neurology | ||||||
| 10/15/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,446 | 54,242 | $966,714 | $425,872 |
| 2022 | 22 | 1,541 | 53,486 | $988,117 | $431,429 |
| 2021 | 24 | 1,569 | 50,380 | $978,989 | $433,167 |
| 2020 | 23 | 1,517 | 40,713 | $828,022 | $365,302 |
Total Patients
6,073
Total Services
198,821
Medicare Billing
$1.7M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 92 | 52,500 | $525,000 | $259,649 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 346 | $75,774 | $31,811 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 313 | $47,263 | $19,479 | 41.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 134 | 212 | $47,700 | $15,301 | 32.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 46 | 118 | $36,166 | $13,755 | 38.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 67 | $27,805 | $8,564 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $23,310 | $8,298 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $20,208 | $8,084 | 40.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 15 | 48 | $12,459 | $7,448 | 59.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 37 | 37 | $19,351 | $6,616 | 34.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 36 | 98 | $14,504 | $5,725 | 39.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 24 | 24 | $14,472 | $5,180 | 35.8% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 16 | 45 | $15,461 | $4,655 | 30.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 46 | $13,018 | $4,493 | 34.5% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 13 | 32 | $10,496 | $4,378 | 41.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 27 | $12,690 | $4,116 | 32.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 27 | 27 | $10,638 | $3,547 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 50 | $7,400 | $3,067 | 41.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 32 | $6,816 | $3,014 | 44.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 16 | $9,120 | $2,725 | 29.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 23 | 23 | $6,877 | $2,216 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $3,528 | $1,546 | 43.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 31 | 31 | $3,658 | $1,264 | 34.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 20 | 20 | $3,000 | $937.80 | 31.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 99 | 51,600 | $516,000 | $250,425 | 48.5% |
About Dr. Gregory Hanes, MD
Dr. Gregory Hanes, MD is a Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255342994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Hanes, MD has received a total of $261,651 in payments from pharmaceutical and medical device companies, with $40,987 received in 2024. These payments were reported across 904 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($195,369).
As a Medicare-enrolled provider, Hanes has provided services to 6,073 Medicare beneficiaries, totaling 198,821 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Sarasota, FL
- Active Since 08/10/2006
- Last Updated 12/12/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1255342994
Products in Payments
- BOTOX (Biological) $157,334
- BOTOX (Drug) $54,010
- UBRELVY (Drug) $18,733
- BOTOX CHRONIC MIGRAINE (Drug) $6,375
- BOTOX NEURO REHAB (Drug) $3,731
- VYVGART (Drug) $3,074
- Gamunex-C (Biological) $2,737
- FIRDAPSE (Drug) $1,733
- INBRIJA (Drug) $498.41
- APTIOM (Drug) $464.02
- Neupro (Drug) $453.27
- ULTOMIRIS (Biological) $405.29
- Hizentra (Biological) $315.49
- Aimovig (Biological) $311.42
- NURTEC ODT (Drug) $305.01
- INGREZZA (Drug) $270.99
- NUPLAZID (Drug) $266.01
- Leqembi (Drug) $254.91
- DUOPA (Drug) $226.92
- AUSTEDO (Drug) $224.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sarasota
Donald Negroski, Md, MD
Neurology — Payments: $1.8M
Neurology $1.8M
Dr. V Kassicieh, D.o, D.O
Neurology — Payments: $403,795
Neurology $403,795
Mauricio Concha, Md, MD
Neurology — Payments: $274,642
Neurology $274,642
Ricardo Gonzalez, Md, MD
Neurology — Payments: $74,673
Neurology $74,673
Dean Sutherland, Md, MD
Neurology — Payments: $67,914
Neurology $67,914
Dr. Ronald Aung-Din, M.d, M.D
Neurology — Payments: $45,214
Neurology $45,214